- Q2 2024 Neuroone Medical Technologies Corp Earnings Call TranscriptMay 14, 2024$1.14 (-0.87%)Earnings
- Q1 2024 Neuroone Medical Technologies Corp Earnings Call TranscriptFeb 13, 2024$1.41 (+2.17%)Earnings
- Q4 2023 Neuroone Medical Technologies Corp Earnings Call TranscriptDec 14, 2023$1.72 (+12.42%)Earnings
- Q3 2023 Neuroone Medical Technologies Corp Earnings Call TranscriptAug 14, 2023$1.09 (+1.96%)Earnings
- Q2 2023 Neuroone Medical Technologies Corp Earnings Call TranscriptMay 11, 2023$1.3 (-3.70%)Earnings
- Neuroone Medical Technologies Corp at Sidoti & Company May Micro-Cap Virtual Conference TranscriptMay 10, 2023
- Q1 2023 Neuroone Medical Technologies Corp Earnings Call TranscriptFeb 14, 2023$1.73 (-16.02%)Earnings
- Q4 2022 Neuroone Medical Technologies Corp Earnings Call TranscriptDec 13, 2022$2.21 (+5.74%)Earnings
- Q3 2022 Neuroone Medical Technologies Corp Earnings Call TranscriptAug 11, 2022$1.89 (-2.33%)Earnings
- Q2 2022 Neuroone Medical Technologies Corp Earnings Call TranscriptMay 12, 2022$0.5394 (+1.75%)Earnings
- Neuroone Medical Technologies Corp at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 21, 2022
- Q1 2022 Neuroone Medical Technologies Corp Earnings Call TranscriptFeb 14, 2022$2.91 (-1.69%)Earnings
- Neuroone Medical Technologies Corp at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 08, 2022
- Q4 2021 Neuroone Medical Technologies Corp Earnings Call TranscriptDec 15, 2021$2.35 (+1.29%)Earnings
Q4 2021 Neuroone Medical Technologies Corp Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the NeuroOne Medical Technologies Corporation fourth-quarter 2021 earnings call. (Operator Instructions). It is now my pleasure to turn the floor over your host, James Carbonara. Sir, the floor is yours.
Thank you, operator, and once again, welcome to the NeuroOne Medical Technologies Corporation fourth-quarter and full-year fiscal 2021 earnings conference call. Today's call will be conducted by the Company's Chief Executive Officer, Dave Rosa; and its Chief Financial Officer, Ron McClurg. Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference call will include forward-looking statements within the meaning of US Federal Securities law with respect to future operations, financial results, events, trends, and performance, which are based on management's beliefs and assumptions as of today's call or other specified date.
Forward-looking statements may involve known and unknown risks, uncertainties and other
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)